Seek expert advice.
NICE suggest that (1):
Emergency referral
Specialist advice
Treatment depends on the stage of the disease.
Early disease (stage I):
Early disseminated infection (stage II):
Late disease (stage III) is generally with high dose IV antibiotics, e.g. ceftriaxone.
NICE have suggested antibiotic treatment for Lyme disease in adults and young people (aged 12 and over) according to symptoms
Lyme disease without focal symptoms
Clinical features | Treatment | First Alternative | Second Alternative |
Erythema migrans and/or Non-focal symptoms | Oral doxycycline: 100 mg twice per day or 200 mg once per day for 21 days | Oral amoxicillin: 1 g 3 times per day for 21 days | Oral azithromycin: 500 mg daily for 17 days |
Lyme disease with focal symptoms
Clinical features | Treatment | First Alternative | Second Alternative |
Lyme disease affecting the cranial nerves or peripheral nervous system | Oral doxycycline: 100 mg twice per day or 200 mg once per day for 21 days | Oral amoxicillin: 1 g 3 times per day for 21 days | - |
Lyme disease affecting the central nervous system | Intravenous ceftriaxone: 2 g twice per day or 4 g once per day for 21 days (when an oral switch is being considered, use doxycycline) | Oral doxycycline: 200 mg twice per day or 400 mg once per day for 21 days | - |
Lyme disease arthritis | Oral doxycycline: 100 mg twice per day or 200 mg once per day for 28 days | Oral amoxicillin: 1 g 3 times per day for 28 days | Intravenous ceftriaxone: 2 g once per day for 28 days |
Acrodermatitis chronica atrophicans | Oral doxycycline: 100 mg twice per day or 200 mg once per day for 28 days | Oral amoxicillin: 1 g 3 times per day for 28 days | Intravenous ceftriaxone: 2 g once per day for 28 days |
Lyme carditis | Oral doxycycline: 100 mg twice per day or 200 mg once per day for 21 days | Intravenous ceftriaxone: 2 g once per day for 21 days | - |
Lyme carditis and haemodynamically unstable | Intravenous ceftriaxone: 2 g once per day for 21 days (when an oral switch is being considered, use doxycycline) | - | - |
Erythromycin is not recommended for the treatment of Lyme borreliosis (LB) due to its high failure rate (4).
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.